My 10-share stock market portfolio for future growth

I have invested in a stock market portfolio of FTSE 350 shares that I expect to continue outperforming these indices over the medium to long term.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Inflation is rampant worldwide. Nevertheless, I believe that — in these difficult times — stock markets still offer the best investment hedge against inflation and excellent long-term return potential for carefully selected shares.

My portfolio

FTSEShareCodeMarket cap (£bn)IndustryYTD % performanceOne-year % performanceThree-year % performance
100AstraZenecaAZN175.8Pharmaceuticals24.1526.5147.23
250BeazleyBEZ3.5Insurance22.1345.240.00
100BunzlBNZL10.6Distribution, logistics-0.358.3342.82
250CapricornCNE0.7Oil, Gas Exploration25.9722.3942.21
100GlencoreGLEN64.9Mining & Trading30.3649.76108.12
250HuntingHTG0.5Energy Industry supplier68.4439.02-37.64
250IndiviorINDV2.1Pharmaceuticals12.0645.31377.45
250MediclinicMDC3.7Health55.5658.1246.85
250SercoSRP2.1Government Services32.1733.5621.93
100SSESSE19.4Power Generation2.512.3046.87
PortfolioAs at 31.8.2227.3033.0569.58

On an equal invested value basis, the portfolio has grown by 69.6% over the past three years (+19.2% per annum). While past performance is no guarantee of future performance, medium to long term I expect the overall portfolio to outperform the FTSE 100 and FTSE 250 indices.

One or two of the stocks may disappoint. Hence, I will actively manage the portfolio and substitute any stocks for which the prospects deteriorate.

AstraZeneca

A British-Swedish multinational pharmaceutical and biotechnology company. It was at the forefront of the rush to develop and distribute a vaccine for Covid-19. Its innovative medicines are used by millions of patients worldwide.

Beazley

A British parent company of worldwide insurance businesses. It underwrites a diverse book of insurance and reinsurance for clients and is a market leader in many of its chosen lines.

Bunzl

A British multinational distribution and outsourcing company. Over 50% of its business is in the food service and food retail sectors.

Capricorn Energy  (previously Cairn Energy)

A British oil and gas exploration and development company. Despite Britain’s net zero objectives, as green billionaire Elon Musk says, “civilization would crumble” if the world stops drilling for oil and gas.

Glencore

An Anglo-Swiss company. One of the world’s largest globally diversified natural resource businesses, being both a mining company and the world’s largest commodities trading firm.

Hunting

A British-based supplier to the oil and gas industry.

Indivior  

A global pharmaceutical company specialising in developing medicines to treat substance use disorders and serious mental illnesses.

Mediclinic International

An international private hospital group with hospitals in South Africa, Namibia, Switzerland and the United Arab Emirates.

Serco

A British contractor for the supply of Government services, primarily in the health, transport, justice, immigration, space, and defense sectors. 55% of the company’s revenue is generated outside the UK.

SSE

Formerly Southern and Scottish Energy, SSE is a multinational energy company that operates UK power stations and offshore wind farms and has a hydroelectric plant in Scotland.

Ian Benfield has positions in AstraZeneca, Beazley, Bunzl, Capricorn Energy, Glencore, Hunting, Indivior, Mediclinic, Serco and SSE. The Motley Fool UK has recommended Bunzl. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

2 top growth stocks to consider for an ISA in April

The UK market is home to some fantastic under-the-radar growth stocks trading at very reasonable valuations. Here are two of…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Could thinking like Warren Buffett help create a market-beating ISA?

Christopher Ruane zooms in on some aspects of Warren Buffett's investing approach he thinks could help an ambitious ISA investor…

Read more »

British pound data
Investing Articles

£10,000 invested in a FTSE 100 index tracker at the start of March is now worth…

Anyone who invested money in a FTSE 100 index tracker at the start of the month may wish to look…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Should investors consider Rolls-Royce shares as war rocks global markets?

Investors who thought Rolls-Royce shares had grown too expensive might have second thoughts as Iran turmoil rattles the FTSE 100,…

Read more »

Young black woman walking in Central London for shopping
Investing Articles

Some lucky ISA investors could pick up £2,000 for free in the next month. Here’s how

The UK government is handing out free money to some ISA investors to help them save for retirement. Here’s a…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Is this the best time to buy dividend shares since Covid-19?

A volatile stock market gives investors a chance to buy shares with unusually high dividend yields. Stephen Wright highlights one…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Are we staring at a once-in-a-decade chance to buy this beaten-down UK growth stock?

Investors couldn't get enough of this FTSE 100 growth stock, but the last 10 years have been pretty frustrating. Could…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

What I look for when searching for shares to buy

There’s a lot that goes into finding shares to buy. Ultimately though, it comes down to two things: numbers that…

Read more »